On August 26, 2017, Resverlogix supported a satellite symposium at the at the European Society of Cardiology (ESC) Congress in Barcelona, Spain: "Managing Diabetes & CVD: Is epigenetics a new way forward?"
Introduction - Lina Badimon, MD – Barcelona, Spain.
Stephen Nicholls, MD - Adelaide, Australia. "Insights from the first trials in epigenetics in human: What is the way forward?"
Erik Stroes, MD - Academic Medical Centre, Amsterdam, Netherlands. "Promise of epigenetic modulation as a target in atherosclerotic patients."
Kausik Ray, MD - Imperial College London, United Kingdom. "The Clinical Unmet need in the patient with Diabetes and ACS?"
Video Presentations & Symposium Highlights can be accessed HERE